Trial · NCT00232596
Adverse events284
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 284
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dizziness | Nervous system disorders | Placebo - Double-blind (DB) Phase (Titration and Maintenance) | 21 | 152 | |
| other | Dizziness | Nervous system disorders | Placebo (DB Phase) and Retigabine (Transition Phase) | 19 | 123 | |
| other | Dizziness | Nervous system disorders | Retigabine - DB Phase (Titration and Maintenance) | 62 | 153 | |
| other | Dizziness | Nervous system disorders | Retigabine (DB Phase) and Retigabine (Transition Phase) | 9 | 92 | |
| other | Somnolence | Nervous system disorders | Placebo - Double-blind (DB) Phase (Titration and Maintenance) | 27 | 152 | |
| other | Somnolence | Nervous system disorders | Placebo (DB Phase) and Retigabine (Transition Phase) | 16 | 123 | |
| other | Somnolence | Nervous system disorders | Retigabine - DB Phase (Titration and Maintenance) | 48 | 153 | |
| other | Somnolence | Nervous system disorders | Retigabine (DB Phase) and Retigabine (Transition Phase) | 5 | 92 | |
| other | Fatigue | General disorders | Placebo - Double-blind (DB) Phase (Titration and Maintenance) | 12 | 152 | |
| other | Fatigue | General disorders | Placebo (DB Phase) and Retigabine (Transition Phase) | 11 | 123 | |
| other | Fatigue | General disorders | Retigabine - DB Phase (Titration and Maintenance) | 24 | 153 | |
| other | Fatigue | General disorders | Retigabine (DB Phase) and Retigabine (Transition Phase) | 1 | 92 | |
| other | Confusional state | Psychiatric disorders | Placebo - Double-blind (DB) Phase (Titration and Maintenance) | 3 | 152 | |
| other | Confusional state | Psychiatric disorders | Placebo (DB Phase) and Retigabine (Transition Phase) | 4 | 123 | |
| other | Confusional state | Psychiatric disorders | Retigabine - DB Phase (Titration and Maintenance) | 20 | 153 | |
| other | Confusional state | Psychiatric disorders | Retigabine (DB Phase) and Retigabine (Transition Phase) | 0 | 92 | |
| other | Headache | Nervous system disorders | Placebo - Double-blind (DB) Phase (Titration and Maintenance) | 28 | 152 | |
| other | Headache | Nervous system disorders | Placebo (DB Phase) and Retigabine (Transition Phase) | 9 | 123 | |
| other | Headache | Nervous system disorders | Retigabine - DB Phase (Titration and Maintenance) | 19 | 153 | |
| other | Headache | Nervous system disorders | Retigabine (DB Phase) and Retigabine (Transition Phase) | 5 | 92 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00232596/events